Singapore markets closed

Nektar Therapeutics (NKTR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2850-0.0350 (-2.65%)
As of 11:34AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 242.38M
Enterprise value 56.54M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.78
Price/book (mrq)1.85
Enterprise value/revenue 0.63
Enterprise value/EBITDA -0.23

Trading information

Stock price history

Beta (5Y monthly) 0.91
52-week change 351.72%
S&P500 52-week change 321.23%
52-week high 31.7500
52-week low 30.4100
50-day moving average 30.9446
200-day moving average 30.6632

Share statistics

Avg vol (3-month) 32.43M
Avg vol (10-day) 34.44M
Shares outstanding 5183.62M
Implied shares outstanding 6183.62M
Float 8163.11M
% held by insiders 10.82%
% held by institutions 167.25%
Shares short (28 Mar 2024) 42.36M
Short ratio (28 Mar 2024) 40.96
Short % of float (28 Mar 2024) 42.75%
Short % of shares outstanding (28 Mar 2024) 41.28%
Shares short (prior month 29 Feb 2024) 42.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 323 Aug 2000

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-128.37%

Management effectiveness

Return on assets (ttm)-15.25%
Return on equity (ttm)-110.95%

Income statement

Revenue (ttm)90.12M
Revenue per share (ttm)0.47
Quarterly revenue growth (yoy)8.50%
Gross profit (ttm)N/A
EBITDA -127.41M
Net income avi to common (ttm)-276.06M
Diluted EPS (ttm)-1.4500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)303.62M
Total cash per share (mrq)1.65
Total debt (mrq)230.4M
Total debt/equity (mrq)175.90%
Current ratio (mrq)6.45
Book value per share (mrq)0.68

Cash flow statement

Operating cash flow (ttm)-192.61M
Levered free cash flow (ttm)-63.63M